PSI CRO opens in Taiwan, looks to Hong Kong for 2018

By Melissa Fassbender contact

- Last updated on GMT

(Image: lovelyday12)
(Image: lovelyday12)

Related tags: Asia pacific, Ulcerative colitis

The Switzerland-headquartered contract research organization (CRO) has opened offices in Taiwan following a string of investments in the Asia Pacific region.

The new office will be listed as Taiwan PSI Health Development Co. Ltd.

According to the CRO, its expansion​ has been driven by demand in oncology, infections, IBD (ulcerative colitis, Crohn’s Disease), and other therapeutic areas.

Taiwan is an important contributor to global clinical trials​,” said Olga Alfonsova, head of corporate development at PSI CRO.

That’s why PSI has opened an office in Taipei and will continue to grow within the country to access the most prominent investigative sites in the areas of oncology, infections, inflammatory bowel diseases, neurology and other therapeutic areas​,” she told us.

The Switzerland-based company is “perfectly on track​” with its plans to expand into Asia Pacific, said Alfonsova. So far this year the company has established offices in Sydney, Australia; Seoul, South Korea, and Taipei; Taiwan.

Alfonsova explained Hong Kong will be next at the beginning of 2018.

The expansion into Asia Pacific region is well-paced and allows global sponsors access to Asian populations across a variety of therapeutic indications​,” she added.

Related news

Show more

Related products

show more

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

baxter_bloomington_facility_larger

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Related suppliers